Search Within

Shanu Modi

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Meeting Abstract (15)
  2. Journal Article (14)
  3. Review (1)
Groups
  1. Breast Medicine Service (30)
  2. Department of Medicine (30)
  3. Molecular Imaging and Therapy Service (30)
  4. Radiology, Department of (30)
  5. Solid Tumor Oncology Division (30)
  6. Survivorship Research (23)

More Groups

People
  1. Clifford Hudis (17)
  2. Komal Jhaveri (12)
  3. Larry Norton (12)
  4. Chau Dang (10)
  5. Gabriela Chiosis (10)
  6. Mark Dunphy (10)

More People

Years
  1. 2024 (2)
  2. 2022 (1)
  3. 2021 (2)
  4. 2020 (2)
  5. 2019 (6)
  6. 2017 (3)

More Years

Publications
  1. Cancer Research (5)
  2. Journal of Clinical Oncology (5)
  3. Annals of Oncology (2)
  4. Clinical Cancer Research (2)
  5. International Journal of Radiation Oncology, Biology, Physics (2)
  6. Breast Cancer Research and Treatment (1)

More Publications

Publishers
  1. American Association for Cancer Research (7)
  2. American Society of Clinical Oncology (6)
  3. Elsevier Inc. (4)
  4. Oxford University Press (3)
  5. American Medical Association (1)
  6. American Society for Biochemistry and Molecular Biology (1)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human evaluation of site-specifically labeled (89)Zr-pertuzumab in patients with HER2-positive breast cancer
    Journal Article

    Yeh, R.; O'Donoghue, J. A.; Jayaprakasam, V. S.; Mauguen, A.; Min, R.; Park, S.; Brockway, J. P.; Bromberg, J. F.; Zhi, W. I.; Robson, M. E.; more...
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): An open-label, randomised, controlled, phase 2 study
    Journal Article

    Tsai, C. J.; Yang, J. T.; Shaverdian, N.; Patel, J.; Shepherd, A. F.; Eng, J.; Guttmann, D.; Yeh, R.; Gelblum, D. Y.; Namakydoust, A.; more...
    Lancet (2024)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2021)

    Fulltext@MSK | Save
  • Immunomodulatory activity of a colony-stimulating factor-1 receptor inhibitor in patients with advanced refractory breast or prostate cancer: A phase I study
    Journal Article

    Autio, K. A.; Klebanoff, C. A.; Schaer, D.; Kauh, J. S. W.; Slovin, S. F.; Adamow, M.; Blinder, V. S.; Brahmachary, M.; Carlsen, M.; Comen, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Measuring tumor epichaperome expression using [(124)I] PU-H71 positron emission tomography as a biomarker of response for PU-H71 plus nab-paclitaxel in HER2-negative metastatic breast cancer
    Journal Article

    Jhaveri, K. L.; dos Anjos, C. H.; Taldone, T.; Wang, R.; Comen, E.; Fornier, M.; Bromberg, J. F.; Ma, W.; Patil, S.; Rodina, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • First-in-human trial of epichaperome-targeted PET in patients with cancer
    Journal Article

    Dunphy, M. P. S.; Pressl, C.; Pillarsetty, N.; Grkovski, M.; Modi, S.; Jhaveri, K.; Norton, L.; Beattie, B. J.; Zanzonico, P. B.; Zatorska, D.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Efficacy and safety of gemcitabine with trastuzumab and pertuzumab after prior pertuzumab-based therapy among patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A phase 2 clinical trial
    Journal Article

    Iyengar, N. M.; Smyth, L. M.; Lake, D.; Gucalp, A.; Singh, J. C.; Traina, T. A.; DeFusco, P.; Fornier, M. N.; Goldfarb, S.; Jhaveri, K.; more...
    JAMA Network Open (2019)

    Fulltext@MSK | Save
  • Paradigms for precision medicine in epichaperome cancer therapy
    Journal Article

    Pillarsetty, N.; Jhaveri, K.; Taldone, T.; Caldas-Lopes, E.; Punzalan, B.; Joshi, S.; Bolaender, A.; Uddin, M. M.; Rodina, A.; Yan, P.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • Copper-64 trastuzumab PET imaging: A reproducibility study
    Journal Article

    Carrasquillo, J. A.; Morris, P. G.; Humm, J. L.; Smith-Jones, P. M.; Beylergil, V.; Akhurst, T.; O'Donoghue, J. A.; Ruan, S.; Modi, S.; Hudis, C. A.; more...
    Quarterly Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save